Evaluation of new potential compounds for the treatment of chromoblastomycosis

Detalhes bibliográficos
Autor(a) principal: Coelho, Rowena Alves
Data de Publicação: 2019
Outros Autores: Luna, Sobrino Joffe, Figueiredo-Carvalho, Maria Helena Galdino, Brito-Santos, Fábio, Rodrigues, Márcio Lourenço, Almeida-Paes, Rodrigo
Tipo de documento: Artigo de conferência
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/46027
Resumo: Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Micologia. Rio de Janeiro, RJ, Brasil.
id CRUZ_eab5b7358eb92ecea01d7b9718c26ebf
oai_identifier_str oai:www.arca.fiocruz.br:icict/46027
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Coelho, Rowena AlvesLuna, Sobrino JoffeFigueiredo-Carvalho, Maria Helena GaldinoBrito-Santos, FábioRodrigues, Márcio LourençoAlmeida-Paes, Rodrigo2021-02-09T22:53:52Z2021-02-09T22:53:52Z2019COELHO, Rowena Alves et al. Evaluation of new potential compounds for the treatment of chromoblastomycosis. In: CONGRESSO BRASILEIRO DE MICROBIOLOGIA, 30., 2019, Maceió-Alagoas. 1 p.https://www.arca.fiocruz.br/handle/icict/46027engCromoblastomicoseAtividade antifúngicaPathogen BoxChromoblastomycosisAntifungal activityPathogen BoxEvaluation of new potential compounds for the treatment of chromoblastomycosisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectFundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Micologia. Rio de Janeiro, RJ, Brasil.Stony Brook University. Department of Microbiology and Immunology. New York, NY, USA.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Micologia. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Micologia. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Carlos Chagas. Laboratório de regulação da expressão gênica. Curitiba, PR, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Micologia. Rio de Janeiro, RJ, Brasil.Chromoblastomycosis (CBM) is a chronic fungal infection of the cutaneous and subcutaneous tissue caused by traumatic implantation, had black fungi of several species as etiological agents. This disease is considered an occupational disease that mainly affects professions related to the handling of soil like the agricultural sector, of civil construction, exposed to contaminated vegetable materials. The most common CBM agents are Fonsecaea species, Phialophora verrucosa, Cladophialophora carrionii, Rhinocladiella aquaspersa, Rhinocladiella similis, Exophiala dermatitidis, Exophiala jeanselmei and others. There is no standard of CBM treatment to follow, requiring more than one drug to be administered and physical methods in most cases. Itraconazole (ITZ) and terbinafine (TRB) are the drugs most commonly used. There are few antifungals that can be used in the treatment of CBM, the refractoriness of some cases and potential recurrences this mycosis, a preclinical study involving compounds already established for other diseases and with known cytotoxicity will allow an evaluation of potential new drugs that may be included in clinical trials for the treatment of CBM in the future. Thus, the objective of this study was to evaluate the antifungal activity of 400 molecules present in Pathogen box against CBM agents. The initial screening with Fonsecaea pedrosoi strain highlighted two compounds: MMV021013 and MMV688978 that presented MIC values between 1.25-5µM and 1.25-2.5µM, respectively, against different CBM agents. The in vitro MIC determination was followed by EUCAST protocol. The analysis of potential synergism of these compounds with the drugs already used in the treatment of this disease (ITZ and TRB) was also be performed. Through these results will can to selected compounds that may be used as promising drugs in the treatment or prophylaxis of CBM in the future.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALRowena Coelho.pdfRowena Coelho.pdfapplication/pdf491453https://www.arca.fiocruz.br/bitstream/icict/46027/2/Rowena%20Coelho.pdff0612fb8d2289d93cdf34e1ef280bf11MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/46027/3/license.txt5a560609d32a3863062d77ff32785d58MD53TEXTRowena Coelho.pdf.txtRowena Coelho.pdf.txtExtracted texttext/plain5035https://www.arca.fiocruz.br/bitstream/icict/46027/4/Rowena%20Coelho.pdf.txt6d4be006501920589a0ff8bd840ad6c8MD54icict/460272021-02-10 10:46:22.782oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-02-10T13:46:22Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Evaluation of new potential compounds for the treatment of chromoblastomycosis
title Evaluation of new potential compounds for the treatment of chromoblastomycosis
spellingShingle Evaluation of new potential compounds for the treatment of chromoblastomycosis
Coelho, Rowena Alves
Cromoblastomicose
Atividade antifúngica
Pathogen Box
Chromoblastomycosis
Antifungal activity
Pathogen Box
title_short Evaluation of new potential compounds for the treatment of chromoblastomycosis
title_full Evaluation of new potential compounds for the treatment of chromoblastomycosis
title_fullStr Evaluation of new potential compounds for the treatment of chromoblastomycosis
title_full_unstemmed Evaluation of new potential compounds for the treatment of chromoblastomycosis
title_sort Evaluation of new potential compounds for the treatment of chromoblastomycosis
author Coelho, Rowena Alves
author_facet Coelho, Rowena Alves
Luna, Sobrino Joffe
Figueiredo-Carvalho, Maria Helena Galdino
Brito-Santos, Fábio
Rodrigues, Márcio Lourenço
Almeida-Paes, Rodrigo
author_role author
author2 Luna, Sobrino Joffe
Figueiredo-Carvalho, Maria Helena Galdino
Brito-Santos, Fábio
Rodrigues, Márcio Lourenço
Almeida-Paes, Rodrigo
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Coelho, Rowena Alves
Luna, Sobrino Joffe
Figueiredo-Carvalho, Maria Helena Galdino
Brito-Santos, Fábio
Rodrigues, Márcio Lourenço
Almeida-Paes, Rodrigo
dc.subject.other.pt_BR.fl_str_mv Cromoblastomicose
Atividade antifúngica
Pathogen Box
topic Cromoblastomicose
Atividade antifúngica
Pathogen Box
Chromoblastomycosis
Antifungal activity
Pathogen Box
dc.subject.en.pt_BR.fl_str_mv Chromoblastomycosis
Antifungal activity
Pathogen Box
description Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Micologia. Rio de Janeiro, RJ, Brasil.
publishDate 2019
dc.date.issued.fl_str_mv 2019
dc.date.accessioned.fl_str_mv 2021-02-09T22:53:52Z
dc.date.available.fl_str_mv 2021-02-09T22:53:52Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/conferenceObject
format conferenceObject
status_str publishedVersion
dc.identifier.citation.fl_str_mv COELHO, Rowena Alves et al. Evaluation of new potential compounds for the treatment of chromoblastomycosis. In: CONGRESSO BRASILEIRO DE MICROBIOLOGIA, 30., 2019, Maceió-Alagoas. 1 p.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/46027
identifier_str_mv COELHO, Rowena Alves et al. Evaluation of new potential compounds for the treatment of chromoblastomycosis. In: CONGRESSO BRASILEIRO DE MICROBIOLOGIA, 30., 2019, Maceió-Alagoas. 1 p.
url https://www.arca.fiocruz.br/handle/icict/46027
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/46027/2/Rowena%20Coelho.pdf
https://www.arca.fiocruz.br/bitstream/icict/46027/3/license.txt
https://www.arca.fiocruz.br/bitstream/icict/46027/4/Rowena%20Coelho.pdf.txt
bitstream.checksum.fl_str_mv f0612fb8d2289d93cdf34e1ef280bf11
5a560609d32a3863062d77ff32785d58
6d4be006501920589a0ff8bd840ad6c8
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009287850491904